CA
CHI Advisors Portfolio holdings
AUM
$252M
This Quarter Return
-1.7%
1 Year Return
+57.46%
3 Year Return
+78.52%
5 Year Return
–
10 Year Return
–
AUM
$301M
AUM Growth
+$301M
(-12%)
Cap. Flow
-$11.6M
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
86.7%
Holding
20
New
1
Increased
12
Reduced
5
Closed
–
Top Buys
| 1 |
Compass Therapeutics
CMPX
|
$9.59M |
| 2 |
IMA
ImageneBio, Inc. Common Stock
IMA
|
$6.27M |
| 3 |
Cullinan Oncology
CGEM
|
$3.58M |
| 4 |
Kezar Life Sciences
KZR
|
$3.3M |
| 5 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
$3.13M |
Top Sells
| 1 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$43.9M |
| 2 |
Repare Therapeutics
RPTX
|
$433K |
| 3 |
Precision BioSciences
DTIL
|
$297K |
| 4 |
INZY
Inozyme Pharma
INZY
|
$192K |
| 5 |
AKUS
Akouos, Inc. Common Stock
AKUS
|
$186K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RXDX
1
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $69.3M | 23% |
1,752,243
-1,109,816
| -39% | -$43.9M |
|
|
2
Repare Therapeutics
RPTX
$71.7M
| $46.7M | 15.49% |
2,212,256
-20,527
| -0.9% | -$433K |
|
|
3
Cullinan Oncology
CGEM
$445M
| $38.2M | 12.68% |
2,476,720
+231,879
| +10% | +$3.58M |
|
4
Pliant Therapeutics
PLRX
$101M
| $34.7M | 11.51% |
2,569,479
+84,755
| +3% | +$1.14M |
|
5
Larimar Therapeutics
LRMR
$310M
| $16.3M | 5.43% |
1,515,148
| – | – |
|
|
VECT
6
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $13.1M | 4.36% |
2,675,408
+82,806
| +3% | +$407K |
|
|
OMGA
7
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $12M | 3.97% |
1,055,882
| – | – |
|
|
ONCR
8
DELISTED
Oncorus, Inc.
ONCR
| $11.1M | 3.69% |
2,106,903
+350,924
| +20% | +$1.85M |
|
|
IMA
9
ImageneBio, Inc. Common Stock
IMA
$150M
| $10.2M | 3.39% |
814,756
+499,756
| +159% | +$6.27M |
|
|
10
Compass Therapeutics
CMPX
$483M
| $9.59M | 3.18% |
+3,023,692
| New | +$9.59M |
|
|
ORTX
11
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $8.51M | 2.83% |
6,449,856
+2,367,884
| +58% | +$3.13M |
|
|
AKUS
12
DELISTED
Akouos, Inc. Common Stock
AKUS
| $7.11M | 2.36% |
836,120
-21,907
| -3% | -$186K |
|
|
INZY
13
DELISTED
Inozyme Pharma
INZY
| $6.08M | 2.02% |
892,057
-28,207
| -3% | -$192K |
|
|
14
Kezar Life Sciences
KZR
$28.9M
| $4.55M | 1.51% |
272,250
+197,250
| +263% | +$3.3M |
|
|
15
Precision BioSciences
DTIL
$57.8M
| $4.49M | 1.49% |
606,629
-40,100
| -6% | -$297K |
|
|
FRLN
16
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $3.72M | 1.23% |
1,876,389
+448,908
| +31% | +$889K |
|
|
GTHX
17
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $2.35M | 0.78% |
230,000
+180,000
| +360% | +$1.84M |
|
18
Ovid Therapeutics
OVID
$91M
| $1.28M | 0.43% |
400,000
+166,490
| +71% | +$534K |
|
19
Keros Therapeutics
KROS
$618M
| $1.03M | 0.34% |
17,518
+4,891
| +39% | +$286K |
|
20
Corvus Pharmaceuticals
CRVS
$428M
| $964K | 0.32% |
400,000
+234,073
| +141% | +$564K |
|